By otakuyassine3@gmail.com 
Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $65.25, for a total value of $2,283,750.00. Following the completion of the sale, the director now owns 6,209 shares of the company’s stock, valued at $405,137.25. The trade was a 84.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Thursday, January 23rd, Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock. The shares were sold at an average price of $65.12, for a total value of $682,783.20.
- On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.35, for a total value of $2,322,250.00.
- On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.15, for a total transaction of $2,350,250.00.
- On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00.
- On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96.
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total transaction of $5,915.00.
- On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00.
Ryan Specialty Stock Up 0.7 %
Shares of RYAN stock opened at $65.91 on Thursday. Ryan Specialty Holdings, Inc. has a twelve month low of $42.21 and a twelve month high of $75.97. The stock has a market cap of $17.26 billion, a P/E ratio of 85.59, a P/E/G ratio of 1.14 and a beta of 0.72. The stock has a 50 day moving average of $67.04 and a 200 day moving average of $66.40. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same period in the previous year, the firm earned $0.32 EPS. The business’s quarterly revenue was up 20.5% on a year-over-year basis. As a group, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.
Analyst Ratings Changes
RYAN has been the topic of a number of analyst reports. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective on the stock. Wells Fargo & Company reduced their price target on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. The Goldman Sachs Group increased their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Finally, Bank of America boosted their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $74.40.
Get Our Latest Stock Report on Ryan Specialty
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in RYAN. Hollencrest Capital Management acquired a new stake in shares of Ryan Specialty during the 3rd quarter valued at about $25,000. Assetmark Inc. purchased a new position in Ryan Specialty during the third quarter worth approximately $34,000. Quarry LP grew its holdings in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares during the period. GAMMA Investing LLC grew its holdings in Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after purchasing an additional 644 shares during the period. Finally, Signaturefd LLC increased its position in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
Receive News & Ratings for Ryan Specialty Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Ryan Specialty and related companies with MarketBeat.com’s FREE daily email newsletter.